Development Of Neuroimaging Methods To Assess The Neurobiology Of Addiction

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorNational Institute on Alcohol Abuse and Alcoholism (NIAAA)

About this trial

Background:

Abusing alcohol, drugs, and other substances can cause serious health problems. These substances also can affect brain function. Researchers want to learn more about brain function by using magnetic resonance imaging (MRI). This uses a magnetic field and radio waves to take pictures of the brain.

Objective:

To develop new ways to use MRI to study the brain.

Eligibility:

Healthy people 18 years of age or older.

Design:

Participants will be screened with a medical history, physical exam, and blood and urine tests.

They will answer questions about their drug use and psychiatric history. They will be asked about family history of alcoholism or drug abuse.

Participants will answer questions to see if they can participate in MRI.

Participants will have MRI scans. The scanner is a metal cylinder in a strong magnetic field. Participants will lie on a table that slides in and out of the cylinder. A device called a coil may be placed over the head.

Each sub-study will include up to 3 different MRI visits. Participants can be in multiple sub-studies. But they can have only 1 MRI per week and 20 per year.

During MRI visits, participants may have urine collected. They may get another MRI questionnaire.

Participants may have a clinical MRI brain scan. This may show physical problems in the brain.

During some scans, participants may perform simple movement, memory, and thinking tasks.

Participants may be connected to a machine to monitor brain activity during the scan. Small metal electrodes will be placed on the scalp. A gel will be placed in the space between the electrodes and the scalp.

Eligibility criteria

Qualifiers

Eighteen years or older.

Ability to provide written informed consent as determined by physical examination and verbal communication. Capacity to consent will be determined by those obtaining the informed consent.

Willingness to abstain from drug use on scheduled testing days.

Disqualifiers

Positive urine pregnancy test in females.

Presence of ferromagnetic objects in the body that are contraindicated for MRI of the head (including but not limited to pacemakers or other implanted electrical devices, brain stimulators, some types of dental implants, aneurysm clips, metallic prostheses, permanent eyeliner, implanted delivery pump, or shrapnel fragments) or fear of enclosed spaces as determined by the self-report checklist.

Claustrophobia.

Body weight >550 lbs, which is the weight limit of the MR scanner.

Trial design

Treatments tested in this trial

  • In vivo MRS
  • fMRI
  • EEG/EOG
  • Stimulation tasks
  • NSPRD
  • Structural MRI

Treatment groups

192 Participants
are divided into 9 treatment groups

9

Treatment groups

See each treatment group below.

Locations

1
National Institutes of Health Clinical Center20892, BethesdaMaryland, United States

Sponsors and collaborators

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Lead sponsor